Singh Akanksha, Mankotia Dhananjay Singh, Irshad Mohammad
Clinical Biochemistry Division, Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi-110029, India.
J Transl Int Med. 2017 Mar 31;5(1):34-42. doi: 10.1515/jtim-2017-0010. eCollection 2017 Mar.
The variable response of hepatitis C virus (HCV) genotypes towards anti-viral treatment requires prior information on the genotype status before planning a therapeutic strategy. Although assays for typing or subtyping of HCV are available, however, a fast and reliable assay system is still needed. The present study was planned to develop a single-step multiplex quantitative real time polymerase chain reaction (qPCR) assay to determine HCV genotypes in patients' sera.
The conserved sequences from 5' UTR, core and NS5b regions of HCV genome were used to design primers and hydrolysis probes labeled with fluorophores. Starting with the standardization of singleplex (qPCR) for each individual HCV-genotype, the experimental conditions were finally optimized for the development of multiplex assay. The sensitivity and specificity were assessed both for singleplex and multiplex assays. Using the template concentration of 10 copies per microliter, the value of quantification cycle (Cq) and the limit of detection (LOD) were also compared for both singleplex and multiplex assays. Similarly, the merit of multiplex assay was also compared with sequence analysis and restriction fragment length polymorphism (RFLP) techniques used for HCV genotyping. In order to find the application of multiplex qPCR assay, it was used for genotyping in a panel of 98 sera positive for HCV RNA after screening a total number of 239 patients with various liver diseases.
The results demonstrated the presence of genotype 1 in 26 of 98 (26.53%) sera, genotype 3 in 65 (66.32%) and genotype 4 in 2 (2.04%) sera samples, respectively. One sample showed mixed infection of genotype 1 and 3. Five samples could not show the presence of any genotype. Genotypes 2, 5 and 6 could not be detected in these sera samples. The analysis of sera by singleplex and RFLP indicated the results of multiplex to be comparable with singleplex and with clear merit of multiplex over RFLP. In addition, the results of multiplex assay were also found to be comparable with those from sequence analysis. The sensitivity, specificity, Cq values and LOD values were compared and found to be closely associated both for singleplex and multiplex assays.
The multiplex qPCR assay was found to be a fast, specific and sensitive method that can be used as a technique of choice for HCV genotyping in all routine laboratories.
丙型肝炎病毒(HCV)基因型对抗病毒治疗的反应各异,因此在制定治疗策略前需要了解基因型状态。尽管已有HCV分型或亚型分析方法,但仍需要一种快速可靠的检测系统。本研究旨在开发一种单步多重定量实时聚合酶链反应(qPCR)检测方法,用于测定患者血清中的HCV基因型。
利用HCV基因组5'UTR、核心区和NS5b区的保守序列设计引物和荧光标记的水解探针。从对每种HCV基因型的单重(qPCR)进行标准化开始,最终优化实验条件以开发多重检测方法。对单重和多重检测方法的灵敏度和特异性进行评估。使用每微升10拷贝的模板浓度,还比较了单重和多重检测方法的定量循环(Cq)值和检测限(LOD)。同样,还将多重检测方法的优点与用于HCV基因分型的序列分析和限制性片段长度多态性(RFLP)技术进行了比较。为了探究多重qPCR检测方法的应用,在对239例各种肝病患者进行筛查后,将其用于对98份HCV RNA阳性血清进行基因分型。
结果显示,98份血清样本中,分别有26份(26.53%)为基因型1,65份(66.32%)为基因型3,2份(2.04%)为基因型4。1份样本显示基因型1和3混合感染。5份样本未检测到任何基因型。2、5和6型在这些血清样本中未被检测到。单重检测和RFLP对血清的分析表明,多重检测结果与单重检测结果相当,且多重检测明显优于RFLP。此外,还发现多重检测结果与序列分析结果相当。比较了单重和多重检测方法的灵敏度、特异性、Cq值和LOD值,发现二者密切相关。
多重qPCR检测方法是一种快速、特异且灵敏的方法,可作为所有常规实验室进行HCV基因分型的首选技术。